{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:49:33Z","timestamp":1793731773202,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/N\/NZ7\/03094"],"award-info":[{"award-number":["2016\/21\/N\/NZ7\/03094"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010408","name":"Polpharma Scientific Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/DSC\/005323"],"award-info":[{"award-number":["K\/DSC\/005323"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite our poor understanding of the pathophysiology of depression, a growing body of evidence indicates the role of both glutamate and gamma-aminobutyric acid (GABA) signaling behind the effects of rapid-acting antidepressants (RAADs). GPR39 is a zinc-sensing receptor whose activation leads to a prolonged antidepressant-like response in mice. Both GPR39 and zinc can modulate glutamatergic and GABAergic neurotransmission, however, exact molecular mechanisms are still elusive. In this study, we aimed to research the role of glutamatergic and GABAergic system activation in TC-G 1008 antidepressant-like effects and the disruptions in this effect caused by a low-zinc diet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the first part of our study, we investigated the role of joint administration of the GPR39 agonist (TC-G 1008) and ligands of the glutamatergic or GABAergic systems, in antidepressant-like response. To evaluate animal behaviour we used the forced swim test in mice. In the second part of the study, we assessed the effectiveness of TC-G 1008-induced antidepressant-like response in conditions of decreased dietary zinc intake and its molecular underpinning by conducting a Western Blot analysis of selected proteins involved in glutamatergic and GABAergic neurotransmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The TC-G 1008-induced effect was blocked by the administration of NMDA or picrotoxin. The joint administration of TC-G 1008 along with muscimol or SCH50911 showed a trend toward decreased immobility time. Zinc-deficient diet resulted in dysregulation of GluN1, PSD95, and KCC2 protein expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings indicate the important role of glutamate\/GABA signaling in the antidepressant-like effect of TC-G 1008 and imply that GPR39 regulates the balance between excitatory and inhibitory activity in the brain. Thus, we suggest the zinc-sensing receptor be considered an interesting new target for the development of novel antidepressants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s43440-023-00478-0","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:43:08Z","timestamp":1680522188000},"page":"609-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission"],"prefix":"10.1007","volume":"75","author":[{"given":"Gabriela","family":"Starowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Siod\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-8154","authenticated-orcid":false,"given":"Katarzyna","family":"Mlyniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"issue":"11","key":"478_CR1","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.socscimed.2008.01.047","volume":"66","author":"J Moncrieff","year":"2008","unstructured":"Moncrieff J. The creation of the concept of an antidepressant: an historical analysis. Soc Sci Med. 2008;66(11):2346\u201355.","journal-title":"Soc Sci Med"},{"issue":"6","key":"478_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/neu.2017.39","volume":"30","author":"VS Pereira","year":"2018","unstructured":"Pereira VS, Hiroaki-Sato A. A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta neuropsychiatr. 2018;30(6):307\u201322.","journal-title":"Acta neuropsychiatr"},{"issue":"5","key":"478_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","volume":"38","author":"SM Thompson","year":"2015","unstructured":"Thompson SM, Kallarackal AJ, Kvarta MD, Van DAM, Legates TA, Cai X. An excitatory synapse hypothesis of depression. Trends Neurosci. 2015;38(5):279\u201394.","journal-title":"Trends Neurosci"},{"issue":"9","key":"478_CR4","doi-asserted-by":"publisher","first-page":"e1800027","DOI":"10.1002\/bies.201800027","volume":"40","author":"A Inserra","year":"2018","unstructured":"Inserra A, Rogers GB, Licinio J, Wong M. The microbiota-inflammasome hypothesis of major depression. BioEssay. 2018;40(9):e1800027.","journal-title":"BioEssay."},{"issue":"12","key":"478_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/sj.mp.4002075","volume":"12","author":"JO Groves","year":"2007","unstructured":"Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007;12(12):1079\u201388.","journal-title":"Mol Psychiatry"},{"issue":"1\u20133","key":"478_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","volume":"375","author":"P Skolnick","year":"1999","unstructured":"Skolnick P. Antidepressants for the new millennium. Eur J Pharmacol. 1999;375(1\u20133):31\u201340.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"478_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","volume":"185","author":"R Trullas","year":"1990","unstructured":"Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol. 1990;185(1):1\u201310.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"478_CR8","first-page":"95","volume":"269","author":"IA Paul","year":"1994","unstructured":"Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther. 1994;269(1):95\u2013102.","journal-title":"J Pharmacol Exp Ther."},{"issue":"11","key":"478_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","volume":"30","author":"P Skolnick","year":"2009","unstructured":"Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci. 2009;30(11):563\u20139.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"478_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"R Berman","year":"2000","unstructured":"Berman R, Cappiello A, Anand A. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134.","journal-title":"Biol Psychiatry"},{"key":"478_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pharmthera.2018.05.010","volume":"190","author":"CG Abdallah","year":"2018","unstructured":"Abdallah CG, Sanacora G, Duman RS, Krystal JH. The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation? Pharmacol Ther. 2018;190:148\u201358.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"478_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","volume":"32","author":"P Zanos","year":"2018","unstructured":"Zanos P, Thompson SM, Duman RS, Zarate CA Jr, Gould TD. Convergent mechanisms underlying rapid antidepressant action. CNS Drugs. 2018;32(3):197\u2013227.","journal-title":"CNS Drugs"},{"issue":"3","key":"478_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3):238\u201349.","journal-title":"Nat Med"},{"issue":"6103","key":"478_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338(6103):68\u201372.","journal-title":"Science"},{"issue":"1","key":"478_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","volume":"62","author":"H M\u00f6hler","year":"2012","unstructured":"M\u00f6hler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 2012;62(1):42\u201353.","journal-title":"Neuropharmacology"},{"issue":"2","key":"478_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","volume":"64","author":"G Hasler","year":"2007","unstructured":"Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64(2):193\u2013200.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"478_CR17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/mp.2011.113","volume":"17","author":"JP Guilloux","year":"2012","unstructured":"Guilloux JP, Douillard-Guilloux G, Kota R, et al. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry. 2012;17(11):1130\u201342.","journal-title":"Mol Psychiatry"},{"issue":"7897","key":"478_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41586-022-04402-z","volume":"602","author":"VB Kasaragod","year":"2022","unstructured":"Kasaragod VB, Mortensen M, Hardwick SW, et al. Mechanisms of inhibition and activation of extrasynaptic \u03b1\u03b2 GABAA receptors [published correction appears in Nature. 2022 Mar 24]. Nature. 2022;602(7897):529\u201333.","journal-title":"Nature"},{"issue":"20","key":"478_CR19","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1503348112","volume":"112","author":"CT Anderson","year":"2015","unstructured":"Anderson CT, Radford RJ, Zastrow ML, et al. Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc. Proc Natl Acad Sci USA. 2015;112(20):E2705\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"478_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jnr.10600","volume":"72","author":"A Takeda","year":"2003","unstructured":"Takeda A, Hirate M, Tamano H, Oku N. Release of glutamate and GABA in the hippocampus under zinc deficiency. J Neurosci Res. 2003;72(4):537\u201342.","journal-title":"J Neurosci Res"},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainresbull.2015.04.005","volume":"115","author":"K M\u0142yniec","year":"2015","unstructured":"M\u0142yniec K, Gawe\u0142 M, Librowski T, Reczy\u0144ski W, Bystrowska B, Holst B. Investigation of the GPR39 zinc receptor following inhibition of monoaminergic neurotransmission and potentialization of glutamatergic neurotransmission. Brain Res Bull. 2015;115:23\u20139.","journal-title":"Brain Res Bull"},{"key":"478_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.neuropharm.2013.12.001","volume":"79","author":"K M\u0142yniec","year":"2014","unstructured":"M\u0142yniec K, Doboszewska U, Szewczyk B, et al. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims. Neuropharmacology. 2014;79:290\u20137.","journal-title":"Neuropharmacology."},{"key":"478_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jad.2018.11.003","volume":"245","author":"G Starowicz","year":"2019","unstructured":"Starowicz G, Jarosz M, Fr\u0105ckiewicz E, et al. Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008. J Affect Disord. 2019;245:325\u201334.","journal-title":"J Affect Disord"},{"key":"478_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2016.05.007","volume":"201","author":"K M\u0142yniec","year":"2016","unstructured":"M\u0142yniec K, Starowicz G, Gawe\u0142 M, Fr\u0105ckiewicz E, Nowak G. Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist. J Affect Disord. 2016;201:179\u201384.","journal-title":"J Affect Disord"},{"issue":"3","key":"478_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1006\/geno.1997.5069","volume":"46","author":"KK McKee","year":"1997","unstructured":"McKee KK, Tan CP, Palyha OC, et al. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics. 1997;46(3):426\u201334.","journal-title":"Genomics"},{"issue":"5750","key":"478_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1117255","volume":"310","author":"JV Zhang","year":"2005","unstructured":"Zhang JV, Ren P, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin\u2019s effects on food intake. Science. 2005;310(5750):996\u20139.","journal-title":"Science"},{"issue":"1","key":"478_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbrc.2006.09.141","volume":"351","author":"E Lauwers","year":"2006","unstructured":"Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun. 2006;351(1):21\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"478_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/en.2006-0933","volume":"148","author":"B Holst","year":"2007","unstructured":"Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology. 2007;148(1):13\u201320.","journal-title":"Endocrinology"},{"issue":"5813","key":"478_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1126\/science.1135047","volume":"315","author":"N Chartrel","year":"2007","unstructured":"Chartrel N, Alvear-Perez R, Leprince J, et al. Comment on \u201cObestatin, a peptide encoded by the ghrelin gene, opposes ghrelin\u2019s effects on food intake.\u201d Science. 2007;315(5813):766.","journal-title":"Science"},{"issue":"6","key":"478_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/mol.116.106112","volume":"90","author":"S Sato","year":"2016","unstructured":"Sato S, Huang XP, Kroeze WK, Roth BL. Discovery and characterization of novel GPR39 agonists allosterically modulated by zinc. Mol Pharmacol. 2016;90(6):726\u201337.","journal-title":"Mol Pharmacol"},{"issue":"20","key":"478_CR31","doi-asserted-by":"publisher","first-page":"11749","DOI":"10.1073\/pnas.201193398","volume":"98","author":"M Hershfinkel","year":"2001","unstructured":"Hershfinkel M, Moran A, Grossman N, Sekler I. A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci USA. 2001;98(20):11749\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"478_CR32","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1523\/JNEUROSCI.5093-08.2009","volume":"29","author":"L Besser","year":"2009","unstructured":"Besser L, Chorin E, Sekler I, et al. Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J Neurosci. 2009;29(9):2890\u2013901.","journal-title":"J Neurosci"},{"issue":"36","key":"478_CR33","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.1523\/JNEUROSCI.2205-11.2011","volume":"31","author":"E Chorin","year":"2011","unstructured":"Chorin E, Vinograd O, Fleidervish I, et al. Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR\/GPR39 receptor. J Neurosci. 2011;31(36):12916\u201326.","journal-title":"J Neurosci"},{"key":"478_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuroscience.2012.03.001","volume":"210","author":"RA Saadi","year":"2012","unstructured":"Saadi RA, He K, Hartnett KA, Kandler K, Hershfinkel M, Aizenman E. SNARE-dependent upregulation of potassium chloride co-transporter 2 activity after metabotropic zinc receptor activation in rat cortical neurons in vitro. Neuroscience. 2012;210:38\u201346.","journal-title":"Neuroscience"},{"issue":"1","key":"478_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00018-010-0517-1","volume":"68","author":"P Popovics","year":"2011","unstructured":"Popovics P, Stewart AJ. GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci. 2011;68(1):85\u201395.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"478_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/ijms19020439","volume":"19","author":"M Hershfinkel","year":"2018","unstructured":"Hershfinkel M. The zinc sensing receptor, ZnR\/GPR39, in health and disease. Int J Mol Sci. 2018;19(2):439.","journal-title":"Int J Mol Sci"},{"key":"478_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbd.2014.12.020","volume":"81","author":"D Gilad","year":"2015","unstructured":"Gilad D, Shorer S, Ketzef M, et al. Homeostatic regulation of KCC2 activity by the zinc receptor mZnR\/GPR39 during seizures. Neurobiol Dis. 2015;81:4\u201313.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"478_CR38","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.pharep.2015.04.003","volume":"67","author":"K M\u0142yniec","year":"2015","unstructured":"M\u0142yniec K, Nowak G. Up-regulation of the GPR39 Zn2+-sensing receptor and CREB\/BDNF\/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice. Pharmacol Rep. 2015;67(6):1135\u201340.","journal-title":"Pharmacol Rep"},{"issue":"10","key":"478_CR39","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1021\/ml500240d","volume":"5","author":"S Peukert","year":"2014","unstructured":"Peukert S, Hughes R, Nunez J, et al. Discovery of 2-pyridylpyrimidines as the first orally bioavailable GPR39 agonists. ACS Med Chem Lett. 2014;5(10):1114\u20138.","journal-title":"ACS Med Chem Lett"},{"key":"478_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejphar.2018.10.038","volume":"842","author":"P Pongkorpsakol","year":"2019","unstructured":"Pongkorpsakol P, Buasakdi C, Chantivas T, Chatsudthipong V, Muanprasat C. An agonist of a zinc-sensing receptor GPR39 enhances tight junction assembly in intestinal epithelial cells via an AMPK-dependent mechanism. Eur J Pharmacol. 2019;842:306\u201313.","journal-title":"Eur J Pharmacol"},{"key":"478_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejphar.2018.07.045","volume":"834","author":"S Muneoka","year":"2018","unstructured":"Muneoka S, Goto M, Kadoshima-Yamaoka K, Kamei R, Terakawa M, Tomimori Y. G protein-coupled receptor 39 plays an anti-inflammatory role by enhancing IL-10 production from macrophages under inflammatory conditions. Eur J Pharmacol. 2018;834:240\u20135.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"478_CR42","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41386-018-0308-1","volume":"44","author":"VC Cuzon Carlson","year":"2019","unstructured":"Cuzon Carlson VC, Ford MM, Carlson TL, et al. Modulation of Gpr39, a G-protein coupled receptor associated with alcohol use in non-human primates, curbs ethanol intake in mice. Neuropsychopharmacology. 2019;44(6):1103\u201313.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"478_CR43","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S1734-1140(13)71080-6","volume":"65","author":"M Wolak","year":"2013","unstructured":"Wolak M, Siwek A, Szewczyk B, et al. Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. Pharmacol Rep. 2013;65(4):991\u20137.","journal-title":"Pharmacol Rep"},{"issue":"3","key":"478_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.pharep.2014.12.003","volume":"67","author":"M Wolak","year":"2015","unstructured":"Wolak M, Siwek A, Szewczyk B, et al. Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice. Pharmacol Rep. 2015;67(3):490\u20133.","journal-title":"Pharmacol Rep."},{"issue":"11","key":"478_CR45","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00702-011-0630-9","volume":"118","author":"E Poleszak","year":"2011","unstructured":"Poleszak E, Wla\u017a P, Szewczyk B, et al. A complex interaction between glycine\/NMDA receptors and serotonergic\/noradrenergic antidepressants in the forced swim test in mice. J Neural Transm (Vienna). 2011;118(11):1535\u201346.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"478_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00726-009-0412-y","volume":"39","author":"B Szewczyk","year":"2010","unstructured":"Szewczyk B, Poleszak E, Sowa-Ku\u0107ma M, et al. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids. 2010;39(1):205\u201317.","journal-title":"Amino Acids"},{"issue":"11","key":"478_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00702-008-0128-2","volume":"115","author":"M Dyba\u0142a","year":"2008","unstructured":"Dyba\u0142a M, Siwek A, Poleszak E, Pilc A, Nowak G. Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test. J Neural Transm (Vienna). 2008;115(11):1519\u201320.","journal-title":"J Neural Transm (Vienna)"},{"issue":"7604","key":"478_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533(7604):481\u20136.","journal-title":"Nature"},{"issue":"22","key":"478_CR49","doi-asserted-by":"publisher","first-page":"9259","DOI":"10.1523\/JNEUROSCI.0237-13.2013","volume":"33","author":"T Perez-Rosello","year":"2013","unstructured":"Perez-Rosello T, Anderson CT, Schopfer FJ, et al. Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis [published correction appears in J Neurosci. 2014 May 21; 34(21):7394]. J Neurosci. 2013;33(22):9259\u201372.","journal-title":"J Neurosci."},{"issue":"4","key":"478_CR50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/npp.2009.203","volume":"35","author":"D Chandra","year":"2010","unstructured":"Chandra D, Halonen LM, Linden AM, et al. Prototypic GABA(A) receptor agonist muscimol acts preferentially through forebrain high-affinity binding sites. Neuropsychopharmacology. 2010;35(4):999\u20131007.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"478_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s002130050148","volume":"128","author":"A Dalvi","year":"1996","unstructured":"Dalvi A, Rodgers RJ. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology. 1996;128(4):380\u201397.","journal-title":"Psychopharmacology"},{"issue":"4","key":"478_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00424-014-1547-6","volume":"467","author":"P Blaesse","year":"2015","unstructured":"Blaesse P, Schmidt T. K-Cl cotransporter KCC2\u2013a moonlighting protein in excitatory and inhibitory synapse development and function. Pflugers Arch. 2015;467(4):615\u201324.","journal-title":"Pflugers Arch"},{"issue":"12","key":"478_CR53","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.tins.2013.08.006","volume":"36","author":"KT Kahle","year":"2013","unstructured":"Kahle KT, Deeb TZ, Puskarjov M, et al. Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2. Trends Neurosci. 2013;36(12):726\u201337.","journal-title":"Trends Neurosci"},{"issue":"9","key":"478_CR54","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tins.2017.06.008","volume":"40","author":"YE Moore","year":"2017","unstructured":"Moore YE, Kelley MR, Brandon NJ, Deeb TZ, Moss SJ. Seizing control of KCC2: a new therapeutic target for epilepsy. Trends Neurosci. 2017;40(9):555\u201371.","journal-title":"Trends Neurosci"},{"issue":"1","key":"478_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","volume":"26","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Kaupmann K. Don\u2019t worry \u201cB\u201d happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci. 2005;26(1):36\u201343.","journal-title":"Trends Pharmacol Sci"},{"key":"478_CR56","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1054-3589(10)58016-5","volume":"58","author":"JF Cryan","year":"2010","unstructured":"Cryan JF, Slattery DA. GABAB receptors and depression. Current status Adv Pharmacol. 2010;58:427\u201351.","journal-title":"Current status Adv Pharmacol"},{"issue":"11","key":"478_CR57","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.biopsych.2018.02.006","volume":"83","author":"LH Jacobson","year":"2018","unstructured":"Jacobson LH, Vlachou S, Slattery DA, Li X, Cryan JF. The gamma-aminobutyric acid B receptor in depression and reward. Biol Psychiatry. 2018;83(11):963\u201376.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"478_CR58","doi-asserted-by":"publisher","first-page":"9486","DOI":"10.1038\/s41598-019-45971-w","volume":"9","author":"AA Coley","year":"2019","unstructured":"Coley AA, Gao WJ. PSD-95 deficiency disrupts PFC-associated function and behavior during neurodevelopment. Sci Rep. 2019;9(1):9486.","journal-title":"Sci Rep"},{"issue":"9","key":"478_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046012","volume":"7","author":"J Zhu","year":"2012","unstructured":"Zhu J, Shao CY, Yang W, et al. Chronic zinc exposure decreases the surface expression of NR2A-containing NMDA receptors in cultured hippocampal neurons. PLoS ONE. 2012;7(9): e46012.","journal-title":"PLoS ONE"},{"key":"478_CR60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pnpbp.2014.09.013","volume":"56","author":"U Doboszewska","year":"2015","unstructured":"Doboszewska U, Sowa-Ku\u0107ma M, M\u0142yniec K, et al. Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor. Prog Neuropsychopharmacol Biol Psychiatry. 2015;56:254\u201363.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"478_CR61","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/01.wnr.0000215779.76602.93","volume":"17","author":"VR Jackson","year":"2006","unstructured":"Jackson VR, Nothacker HP, Civelli O. GPR39 receptor expression in the mouse brain. NeuroReport. 2006;17(8):813\u20136.","journal-title":"NeuroReport"},{"issue":"2","key":"478_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.12.024","volume":"85","author":"BJ Molyneaux","year":"2015","unstructured":"Molyneaux BJ, Goff LA, Brettler AC, et al. DeCoN: genome-wide analysis of in vivo transcriptional dynamics during pyramidal neuron fate selection in neocortex [published correction appears in Neuron. 2016 Jan 6; 89(1):235]. Neuron. 2015;85(2):275\u201388.","journal-title":"Neuron."},{"issue":"7772","key":"478_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","volume":"573","author":"RD Hodge","year":"2019","unstructured":"Hodge RD, Bakken TE, Miller JA, et al. Conserved cell types with divergent features in human versus mouse cortex. Nature. 2019;573(7772):61\u20138.","journal-title":"Nature"},{"issue":"7729","key":"478_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41586-018-0654-5","volume":"563","author":"B Tasic","year":"2018","unstructured":"Tasic B, Yao Z, Graybuck LT, et al. Shared and distinct transcriptomic cell types across neocortical areas. Nature. 2018;563(7729):72\u20138.","journal-title":"Nature"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00478-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-023-00478-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00478-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:20:10Z","timestamp":1685406010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-023-00478-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1007\/s43440-023-00478-0","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}